Vamotinib
Vamotinib (PF-114) is an orally active and specific tyrosine kinase inhibitor with antiproliferative and antitumour activity.Vamotinib inhibits the phosphorylation of BCR/ABL and BCR/ABL-T315I, which promotes apoptosis. Vamotinib is used to study drug-resistant Philadelphia chromosome-positive (Ph+) leukaemia and Alzheimer's disease.
Product Specifications
CAS Number
1416241-23-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
532.56
Molecular Formula
C29H27F3N6O
Notes
Research use only, not for human use.
Receptor
Bcr-Abl | Apoptosis | Tyrosine Kinases
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TRC-A161200-100MG 100 mg
2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-D-glucono-1,5-lactone
Ask
View Details 
